Mattia Galli: A Privilege to Collaborate on Such a Complex Topic as Cardio-Rheumatology
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”It is a great privilege to be part of a team of leading experts committed to such a complex and interdisciplinary topic as cardio-rheumatology.”
Title: Antiphospholipid antibodies and cardiovascular thrombosis
Authors: Sina Rashedi, Hannah Leyva, Saman A. Siddiqui, Syed Bukhari, Mariana B. Pfeferman, Nathan W. Watson, Francisco Ujueta, Mehrdad Zarghami, Bassil Bacare, Yogendra Kanthi, David Jimenez, Manuel Monreal, Deborah M. Siegal, Geoffrey D. Barnes, John W. Eikelboom, Michelle L. O’Donoghue, Christian T. Ruff, Mattia Galli, Brittany N. Weber, Samuel Z. Goldhaber, Sacha Uljon, Saskia Middeldorp, Renato D. Lopes, David A. Garcia, Gregory Y. H. Lip, Jeffery I. Weitz, Jean M. Connors, Harlan M. Krumholz, Jason S. Knight, Giuseppe Lippi, Mitchell S. V. Elkind, Mary Cushman, Karen H. Costenbader, Gregory Piazza, Behnood Bikdeli
Read the Full Article on Nature Reviews Cardiology

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026
-
Jun 14, 2026, 19:38Jecko Thachil: Can We Predict and Prevent Bleeding in APL?
-
Jun 14, 2026, 19:32Highlights from Day 1 at the EHC Leadership Conference 2026
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026